TD Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
ACA
UOC
BCM
TAL
TD Asset Management's ISEE Position: Q2 2023 in Review
TD Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 223,218 shares — an estimated $5.43M sold.
TD Asset Management first reported a position in ISEE in Q4 2013 and held it in 25 quarters. The position peaked at $5.43M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- TD Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- TD Asset Management sold 223,218 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $5.43M.
- TD Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 25 quarters.
- TD Asset Management's IVERIC bio, Inc. Common Stock position peaked at $5.43M in Q1 2023.
- 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.